JP2023525762A5 - - Google Patents
Info
- Publication number
- JP2023525762A5 JP2023525762A5 JP2022567895A JP2022567895A JP2023525762A5 JP 2023525762 A5 JP2023525762 A5 JP 2023525762A5 JP 2022567895 A JP2022567895 A JP 2022567895A JP 2022567895 A JP2022567895 A JP 2022567895A JP 2023525762 A5 JP2023525762 A5 JP 2023525762A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- pyrazolo
- methyl
- pyridyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025130117A JP2025183201A (ja) | 2020-05-07 | 2025-08-04 | アデノシンａ２ａ受容体のアンタゴニスト |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2006823.5A GB202006823D0 (en) | 2020-05-07 | 2020-05-07 | Antagonist compounds |
| GB2006823.5 | 2020-05-07 | ||
| GB2019922.0 | 2020-12-16 | ||
| GBGB2019922.0A GB202019922D0 (en) | 2020-12-16 | 2020-12-16 | Antagonist compounds |
| PCT/GB2021/051106 WO2021224636A1 (en) | 2020-05-07 | 2021-05-06 | Antagonists of the adenosine a2a receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130117A Division JP2025183201A (ja) | 2020-05-07 | 2025-08-04 | アデノシンａ２ａ受容体のアンタゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023525762A JP2023525762A (ja) | 2023-06-19 |
| JP2023525762A5 true JP2023525762A5 (https=) | 2024-05-17 |
| JP7724239B2 JP7724239B2 (ja) | 2025-08-15 |
Family
ID=75977772
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567895A Active JP7724239B2 (ja) | 2020-05-07 | 2021-05-06 | アデノシンａ２ａ受容体のアンタゴニスト |
| JP2025130117A Pending JP2025183201A (ja) | 2020-05-07 | 2025-08-04 | アデノシンａ２ａ受容体のアンタゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130117A Pending JP2025183201A (ja) | 2020-05-07 | 2025-08-04 | アデノシンａ２ａ受容体のアンタゴニスト |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP4146654A1 (https=) |
| JP (2) | JP7724239B2 (https=) |
| KR (1) | KR20230035236A (https=) |
| CN (1) | CN115996929B (https=) |
| AU (1) | AU2021266433A1 (https=) |
| BR (1) | BR112022022437A2 (https=) |
| CA (1) | CA3181354A1 (https=) |
| CL (1) | CL2022003055A1 (https=) |
| CO (1) | CO2022017618A2 (https=) |
| EC (1) | ECSP22091613A (https=) |
| GB (1) | GB2609879B (https=) |
| IL (2) | IL297963A (https=) |
| MX (1) | MX2022013946A (https=) |
| PE (1) | PE20230769A1 (https=) |
| PH (1) | PH12022552987A1 (https=) |
| WO (1) | WO2021224636A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4447971A4 (en) * | 2021-12-17 | 2025-12-10 | Merck Sharp & Dohme Llc | PYRAZOLOPYRIMIDINE DERIVATIVES AND THEIR METHODS OF USE FOR THE TREATMENT OF HERPESVIRUS |
| CN116283994B (zh) * | 2021-12-20 | 2025-01-07 | 艾立康药业股份有限公司 | 作为mat2a抑制剂的杂环化合物 |
| CN117247386B (zh) * | 2022-01-18 | 2025-10-24 | 江苏亚尧生物科技有限公司 | 新型吡唑并嘧啶化合物及其组合物、制备方法和用途 |
| JP2025512384A (ja) * | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｒｏｐ－２発現がんを治療するための併用療法 |
| WO2025094087A1 (en) | 2023-10-30 | 2025-05-08 | Johnson & Johnson Enterprise Innovation Inc. | Safe administration of a2a rector antagonist |
| WO2025123251A1 (en) | 2023-12-13 | 2025-06-19 | Johnson & Johnson Enterprise Innovation Inc. | Crystalline forms of a2a receptor antagonist, preparation methods, and uses thereof |
| WO2025123253A1 (en) | 2023-12-13 | 2025-06-19 | Johnson & Johnson Enterprise Innovation Inc. | Pharmaceutical compositions of an a2a receptor antagonist |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
| WO2025202955A1 (en) | 2024-03-28 | 2025-10-02 | Pi Industries Ltd. | Fused bicyclic compounds and their use as pest control agents |
| CN120093763A (zh) * | 2025-03-25 | 2025-06-06 | 上海天龙生物科技有限公司 | 治疗前列腺疾病和腺体类散结节的药物组合物及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910907A (en) * | 1973-07-09 | 1975-10-07 | Icn Pharmaceuticals | Pyrazolo(1,5-a)-1,3,5-triazines |
| US5356897A (en) * | 1991-09-09 | 1994-10-18 | Fujisawa Pharmaceutical Co., Ltd. | 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines |
| US7662826B2 (en) * | 2002-04-23 | 2010-02-16 | Shionogi & Co., Ltd. | Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same |
| US8178533B2 (en) * | 2005-06-01 | 2012-05-15 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| CN101686989B (zh) * | 2007-06-21 | 2016-10-19 | 卡拉治疗学股份有限公司 | 取代的咪唑并杂环 |
| US20100029657A1 (en) | 2008-02-29 | 2010-02-04 | Wyeth | Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof |
| EP2402337A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds |
| EP2402343A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole-fused bicyclic compounds |
| EP2402344A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole fused bicyclic compounds |
| EP2402345A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole fused bicyclic compounds |
| WO2012100342A1 (en) * | 2011-01-27 | 2012-08-02 | Université de Montréal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
| ES2728932T3 (es) * | 2014-01-09 | 2019-10-29 | Intra Cellular Therapies Inc | Compuestos orgánicos |
| CA2969265A1 (en) * | 2014-12-02 | 2016-06-09 | Bayer Pharma Aktiengesellschaft | Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use |
| PE20181326A1 (es) | 2015-11-03 | 2018-08-20 | Janssen Biotech Inc | Anticuerpos que se unen especificamente a pd-1 y sus usos |
| WO2017178844A1 (en) * | 2016-04-15 | 2017-10-19 | Cancer Research Technology Limited | Heterocyclic compounds as ret kinase inhibitors |
| US11608334B2 (en) * | 2017-02-08 | 2023-03-21 | The National Institutes of Pharmaceutical R&D Co., Ltd. | Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
-
2021
- 2021-05-06 EP EP21726445.6A patent/EP4146654A1/en active Pending
- 2021-05-06 GB GB2217519.4A patent/GB2609879B/en active Active
- 2021-05-06 JP JP2022567895A patent/JP7724239B2/ja active Active
- 2021-05-06 WO PCT/GB2021/051106 patent/WO2021224636A1/en not_active Ceased
- 2021-05-06 AU AU2021266433A patent/AU2021266433A1/en active Pending
- 2021-05-06 CA CA3181354A patent/CA3181354A1/en active Pending
- 2021-05-06 BR BR112022022437A patent/BR112022022437A2/pt unknown
- 2021-05-06 IL IL297963A patent/IL297963A/en unknown
- 2021-05-06 KR KR1020227042714A patent/KR20230035236A/ko active Pending
- 2021-05-06 CN CN202180047824.2A patent/CN115996929B/zh active Active
- 2021-05-06 PH PH1/2022/552987A patent/PH12022552987A1/en unknown
- 2021-05-06 MX MX2022013946A patent/MX2022013946A/es unknown
- 2021-05-06 PE PE2022002570A patent/PE20230769A1/es unknown
-
2022
- 2022-11-04 CL CL2022003055A patent/CL2022003055A1/es unknown
- 2022-12-01 EC ECSENADI202291613A patent/ECSP22091613A/es unknown
- 2022-12-06 CO CONC2022/0017618A patent/CO2022017618A2/es unknown
-
2025
- 2025-08-04 JP JP2025130117A patent/JP2025183201A/ja active Pending
- 2025-10-19 IL IL324071A patent/IL324071A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023525762A5 (https=) | ||
| GB2609879A (en) | Antagonists of the adenosine A2a receptor | |
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| US10253019B2 (en) | Tank-binding kinase inhibitor compounds | |
| JP2023506642A5 (https=) | ||
| JP2022548690A5 (https=) | ||
| JP2021502356A5 (https=) | ||
| HRP20140770T1 (hr) | SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS | |
| JP2016523911A5 (https=) | ||
| HRP20212000T1 (hr) | Aminotriazolopiridini kao inhibitori kinaze | |
| HRP20130106T1 (hr) | Imidazotriazini i imidazopirimidini kao inhibitori kinaze | |
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| RU2017124425A (ru) | Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg | |
| JP2019512482A5 (https=) | ||
| JP2010510319A5 (https=) | ||
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| RU2011107437A (ru) | Ингибиторы кинуренин-3-моноксигеназы | |
| JP2016510035A5 (https=) | ||
| EA036452B1 (ru) | Гетероциклические амиды в качестве ингибиторов киназ | |
| JP2014527959A5 (https=) | ||
| JP2018512381A5 (https=) | ||
| RU2009136299A (ru) | Новые производные 3-({1,2,4}триазоло{4,3-а}пиридин-7-ил)бензамида | |
| JP2019535689A5 (https=) | ||
| JP2015510938A5 (https=) | ||
| JP2025540958A (ja) | 蕁麻疹の治療のための野生型ｃ－ｋｉｔキナーゼ阻害剤としてのＮ－フェニル－ピラゾロ［１，５－Ａ］ピリジン－３－カルボキサミド誘導体 |